• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SGLT1 和 EGFR 的共表达与口腔鳞状细胞癌的肿瘤分化有关。

Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.

机构信息

Department of Oral and Maxillofacial Surgery, Oral Restitution, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

Odontology. 2012 Jul;100(2):156-63. doi: 10.1007/s10266-011-0033-2. Epub 2011 May 24.

DOI:10.1007/s10266-011-0033-2
PMID:21607591
Abstract

Overexpression of epidermal growth factor receptor (EGFR) is associated with resistance to chemotherapy and radiotherapy, advanced tumor stage, invasion, metastasis and poor prognosis in malignant tumors. EGFR, therefore, has been an attractive molecular target for chemotherapy. However, the results of clinical studies using inhibitors of its kinase activity have not been promising because the response rates were at most 20%. Sodium-glucose co-transporter 1 (SGLT1) is a membrane protein that mediates the transport of glucose across cellular membranes. EGFR physically associates with and stabilizes SGLT1 to promote glucose uptake into cancer cells through a kinase-independent process. The purpose of this study was to investigate the coexpression of SGLT1 and EGFR and its relationships with clinicopathological features in oral squamous cell carcinoma (OSCC). SGLT1 and EGFR were detected in all OSCC cell lines, and the expression levels of SGLT1 were significantly correlated with those of EGFR. Pearson product-moment correlation coefficient of SGLT1 and EGFR was 0.89 (P = 0.016). The immunohistochemical study using the surgical specimens in 52 patients with tongue SCC also showed a significant correlation between SGLT1 and EGFR. Moreover, SGLT1/EGFR expression was inversely related to tumor differentiation among the 5 clinicopathological factors (P = 0.004). SGLT1/EGFR coexpression might be required in the de-differentiation of OSCC, but further study is needed to clarify the implication of these proteins in the manifestation of malignancy and clinical significance.

摘要

表皮生长因子受体(EGFR)的过表达与化疗和放疗耐药、肿瘤晚期、侵袭、转移和恶性肿瘤预后不良有关。因此,EGFR 一直是化疗的一个有吸引力的分子靶点。然而,使用其激酶活性抑制剂的临床研究结果并不理想,因为反应率最高只有 20%。钠-葡萄糖共转运蛋白 1(SGLT1)是一种膜蛋白,可介导葡萄糖穿过细胞膜的运输。EGFR 与 SGLT1 物理结合并稳定 SGLT1,通过一种非激酶依赖的过程促进葡萄糖进入癌细胞的摄取。本研究旨在探讨 SGLT1 和 EGFR 的共表达及其与口腔鳞状细胞癌(OSCC)临床病理特征的关系。在所有 OSCC 细胞系中均检测到 SGLT1 和 EGFR,SGLT1 的表达水平与 EGFR 的表达水平显著相关。SGLT1 和 EGFR 的 Pearson 积矩相关系数为 0.89(P = 0.016)。对 52 例舌 SCC 患者手术标本的免疫组织化学研究也表明 SGLT1 与 EGFR 之间存在显著相关性。此外,SGLT1/EGFR 表达与 5 个临床病理因素中的肿瘤分化呈负相关(P = 0.004)。SGLT1/EGFR 共表达可能是 OSCC 去分化所必需的,但需要进一步研究来阐明这些蛋白在恶性表型和临床意义中的作用。

相似文献

1
Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.SGLT1 和 EGFR 的共表达与口腔鳞状细胞癌的肿瘤分化有关。
Odontology. 2012 Jul;100(2):156-63. doi: 10.1007/s10266-011-0033-2. Epub 2011 May 24.
2
[Expression analysis of EGFR and SGLT1 in oral squamous cell carcinoma].[表皮生长因子受体(EGFR)和钠-葡萄糖协同转运蛋白1(SGLT1)在口腔鳞状细胞癌中的表达分析]
Kokubyo Gakkai Zasshi. 2011 Mar;78(1):12-8.
3
Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.胰岛素样生长因子 II mRNA 结合蛋白 3 的表达促进肿瘤的形成和侵袭,并预测口腔鳞状细胞癌的预后不良。
J Oral Pathol Med. 2011 Oct;40(9):699-705. doi: 10.1111/j.1600-0714.2011.01019.x. Epub 2011 Feb 25.
4
Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.口腔鳞状细胞癌侵袭前沿的 p53 和 PCNA 表达形式:与临床病理特征和预后的相关性。
J Oral Pathol Med. 2011 Oct;40(9):693-8. doi: 10.1111/j.1600-0714.2011.01032.x. Epub 2011 Apr 18.
5
Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.TGF-β 和组蛋白去乙酰化酶抑制剂对口腔和咽鳞癌细胞系中 podoplanin 表达的正向和负向调控。
Oral Oncol. 2013 Jan;49(1):20-6. doi: 10.1016/j.oraloncology.2012.06.017. Epub 2012 Jul 26.
6
Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.Maspin缺失是口腔鳞状细胞癌侵袭和转移的负性预后因素。
J Oral Pathol Med. 2009 Jul;38(6):535-9. doi: 10.1111/j.1600-0714.2009.00762.x. Epub 2009 Mar 13.
7
Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.环氧化酶-2的表达与口腔鳞状细胞癌中血管内皮生长因子C的表达及淋巴结转移相关。
J Oral Maxillofac Surg. 2013 Oct;71(10):1694-702. doi: 10.1016/j.joms.2013.04.015. Epub 2013 Jul 1.
8
Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.表皮生长因子受体(EGFR)和磷酸化表皮生长因子受体(p-EGFR)在口腔鳞状细胞癌中的免疫组化表达
Pathol Oncol Res. 2006;12(2):87-91. doi: 10.1007/BF02893450. Epub 2006 Jun 24.
9
Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.RPL34 基因对口腔鳞状细胞癌细胞生长和转移的影响。
Arch Oral Biol. 2017 Nov;83:40-46. doi: 10.1016/j.archoralbio.2017.06.035. Epub 2017 Jun 30.
10
Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.表皮生长因子受体(EGFR)在口腔鳞状细胞癌中的免疫组化表达与增殖、凋亡、血管生成及淋巴管生成的关系
Head Neck Oncol. 2010 Jun 25;2:13. doi: 10.1186/1758-3284-2-13.

引用本文的文献

1
Landscape of metabolic alterations and treatment strategies in breast cancer.乳腺癌的代谢改变及治疗策略概况
Genes Dis. 2025 Jan 8;12(5):101521. doi: 10.1016/j.gendis.2025.101521. eCollection 2025 Sep.
2
Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach.将葡萄糖转运蛋白(GLUTs和SGLTs)视为对抗癌症的新型干预手段:药物发现视角与靶向方法
Curr Drug Targets. 2025;26(2):109-131. doi: 10.2174/0113894501335877240926101134.
3
GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma.

本文引用的文献

1
DNA amplification and expression of FADD in oral squamous cell carcinoma.口腔鳞状细胞癌中 FADD 的 DNA 扩增和表达。
J Oral Pathol Med. 2010 Aug 1;39(7):525-32. doi: 10.1111/j.1600-0714.2009.00847.x. Epub 2009 Dec 22.
2
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant.原发性结直肠癌及其相关转移部位中表皮生长因子受体(EGFR)和下游蛋白的不同程度失调可能具有临床相关性。
Br J Cancer. 2009 Apr 7;100(7):1087-94. doi: 10.1038/sj.bjc.6604848. Epub 2009 Mar 17.
3
Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma.
GLUT1 通过结合和稳定磷酸化的 EGFR 促进肺腺癌的细胞增殖。
Cell Commun Signal. 2024 Jun 3;22(1):303. doi: 10.1186/s12964-024-01678-8.
4
Targeting Pivotal Hallmarks of Cancer for Enhanced Therapeutic Strategies in Triple-Negative Breast Cancer Treatment-In Vitro, In Vivo and Clinical Trials Literature Review.针对三阴性乳腺癌治疗中增强治疗策略的癌症关键特征——体外、体内及临床试验文献综述
Cancers (Basel). 2024 Apr 12;16(8):1483. doi: 10.3390/cancers16081483.
5
Prognostic and Clinicopathological Significance of Epidermal Growth Factor Receptor (EGFR) Expression in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.表皮生长因子受体 (EGFR) 表达在口腔鳞状细胞癌中的预后和临床病理意义:系统评价和荟萃分析。
Int J Mol Sci. 2023 Jul 25;24(15):11888. doi: 10.3390/ijms241511888.
6
SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast.SGLT1 作为乳腺浸润性导管癌的不良预后因素。
Breast Cancer Res Treat. 2023 Oct;201(3):499-513. doi: 10.1007/s10549-023-07024-9. Epub 2023 Jul 13.
7
Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma.异柠檬酸脱氢酶(IDH)野生型胶质母细胞瘤中高血糖与分子亚类对生存的影响
Neurooncol Adv. 2022 Oct 11;4(1):vdac163. doi: 10.1093/noajnl/vdac163. eCollection 2022 Jan-Dec.
8
The Role of Glucose Transporters in Oral Squamous Cell Carcinoma.葡萄糖转运蛋白在口腔鳞状细胞癌中的作用。
Biomolecules. 2021 Jul 21;11(8):1070. doi: 10.3390/biom11081070.
9
Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases.SGLT2抑制剂作为人类疾病中强大抗氧化剂的出现。
Antioxidants (Basel). 2021 Jul 22;10(8):1166. doi: 10.3390/antiox10081166.
10
Novel Tyrosine Kinase Targets in Urothelial Carcinoma.尿路上皮癌的新型酪氨酸激酶靶点。
Int J Mol Sci. 2021 Jan 13;22(2):747. doi: 10.3390/ijms22020747.
功能基因组分析确定表皮生长因子受体激活是口腔鳞状细胞癌中最常见的基因事件。
Cancer Res. 2009 Mar 15;69(6):2568-76. doi: 10.1158/0008-5472.CAN-08-3199. Epub 2009 Mar 10.
4
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.癌症中的营养转运体:与瓦尔堡假说及其他方面的关联
Pharmacol Ther. 2009 Jan;121(1):29-40. doi: 10.1016/j.pharmthera.2008.09.005. Epub 2008 Nov 1.
5
Dysregulated molecular networks in head and neck carcinogenesis.头颈部癌变中失调的分子网络。
Oral Oncol. 2009 Apr-May;45(4-5):324-34. doi: 10.1016/j.oraloncology.2008.07.011. Epub 2008 Sep 19.
6
Survival of cancer cells is maintained by EGFR independent of its kinase activity.癌细胞的存活由表皮生长因子受体(EGFR)维持,且与其激酶活性无关。
Cancer Cell. 2008 May;13(5):385-93. doi: 10.1016/j.ccr.2008.03.015.
7
A sweet new role for EGFR in cancer.表皮生长因子受体在癌症中扮演的一个全新角色。
Cancer Cell. 2008 May;13(5):375-6. doi: 10.1016/j.ccr.2008.04.008.
8
ERBB receptors in developing, dysplastic and malignant oral epithelia.发育中的、发育异常的和恶性口腔上皮中的ERBB受体。
Oral Oncol. 2008 Mar;44(3):227-35. doi: 10.1016/j.oraloncology.2007.02.012. Epub 2007 Jun 28.
9
Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas.表皮生长因子受体(EGFR)基因拷贝数扩增与槟榔相关口腔癌颈部淋巴结转移的相关性
Oral Oncol. 2008 Mar;44(3):270-6. doi: 10.1016/j.oraloncology.2007.02.008. Epub 2007 Apr 30.
10
Tyrosine phosphorylation controls PCNA function through protein stability.酪氨酸磷酸化通过蛋白质稳定性来控制增殖细胞核抗原(PCNA)的功能。
Nat Cell Biol. 2006 Dec;8(12):1359-68. doi: 10.1038/ncb1501. Epub 2006 Nov 19.